Lysosomal amino acid transporter LYAAT‐1 in the rat central nervous system: An in situ hybridization and immunohistochemical study

A first mammalian lysosomal transporter (LYAAT‐1) was recently identified and functionally characterized. Preliminary immunocytochemical data revealed that LYAAT‐1 localizes to lysosomes in some neurons. In order to determine whether it is expressed in specific neuron populations and other cell types, and to confirm whether it is localized at the membrane of lysosomes, we used in situ hybridization and immunohistochemistry methods in adult rat central nervous system (CNS). We found that LYAAT‐1 is expressed in most areas of the CNS, specifically in neurons, but also in choroid plexus and ependymal epithelium cells. LYAAT‐1‐IR (immunoreactivity) levels varied among different neuroanatomical structures but were present in neurons independently of the neurotransmitter used (glutamate, GABA, acetylcholine, noradrenaline, serotonin, or glycine). Light and confocal microscopy demonstrated that LYAAT‐1 and the lysosomal marker cathepsin D colocalized throughout the brain and electron microscopy showed that LYAAT‐1‐IR was associated with lysosomal membranes. In addition, LYAAT‐1‐IR was also found associated with other membranes belonging to the Golgi apparatus and lateral saccules and less frequently with multivesicular bodies, endoplasmic reticulum, and occasionally with the plasma membrane. The localization of LYAAT‐1 at the lysosomal membrane is consistent with the view that it mediates amino acid efflux from lysosomes. Furthermore, its cell expression pattern suggests that it may contribute to specialized cellular function in the rat CNS such as neuronal metabolism, neurotransmission, and control of brain amino acid homeostasis. J. Comp. Neurol. 462:71–89, 2003. © 2003 Wiley‐Liss, Inc.

[1]  J. Stern,et al.  Hyperprolinaemia type 2. , 2008, Journal of mental deficiency research.

[2]  H. Daniel,et al.  Functional Characterization of Two Novel Mammalian Electrogenic Proton-dependent Amino Acid Cotransporters* , 2002, The Journal of Biological Chemistry.

[3]  C. S. Pillay,et al.  Endolysosomal proteolysis and its regulation. , 2002, The Biochemical journal.

[4]  F. Rivier,et al.  Is Hyperprolinemia Type I Actually a Benign Trait? Report of a Case With Severe Neurologic Involvement and Vigabatrin Intolerance , 2001, Journal of child neurology.

[5]  F. Gu,et al.  Trans-Golgi network sorting , 2001, Cellular and Molecular Life Sciences CMLS.

[6]  B. Giros,et al.  Identification and characterization of a lysosomal transporter for small neutral amino acids , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[7]  R. Farrant,et al.  Pyridoxal Phosphate De-activation by Pyrroline-5-carboxylic Acid , 2001, The Journal of Biological Chemistry.

[8]  Y. Ioannou,et al.  Transmembrane molecular pump activity of Niemann-Pick C1 protein. , 2000, Science.

[9]  M. Baumgartner,et al.  Hyperammonemia with reduced ornithine, citrulline, arginine and proline: a new inborn error caused by a mutation in the gene encoding delta(1)-pyrroline-5-carboxylate synthase. , 2000, Human molecular genetics.

[10]  P. Mathews,et al.  The Endosomal-Lysosomal System of Neurons in Alzheimer's Disease Pathogenesis: A Review , 2000, Neurochemical Research.

[11]  Shivananda,et al.  Type I hyperprolinemia , 2000, Indian journal of pediatrics.

[12]  S. Adibi,et al.  Characterization of an oligopeptide transporter in renal lysosomes. , 2000, Biochimica et biophysica acta.

[13]  G. Mancini,et al.  Lysosomal transport disorders , 2000, Journal of Inherited Metabolic Disease.

[14]  Tianxin Yang,et al.  Localization of PEPT1 and PEPT2 proton-coupled oligopeptide transporter mRNA and protein in rat kidney. , 1999, American journal of physiology. Renal physiology.

[15]  M. Karayiorgou,et al.  The gene encoding proline dehydrogenase modulates sensorimotor gating in mice , 1999, Nature Genetics.

[16]  E. Lemyre,et al.  Clinical spectrum of infantile free sialic acid storage disease. , 1999, American journal of medical genetics.

[17]  A. Craig,et al.  Localization of the Brain-Specific High-Affinity l -Proline Transporter in Cultured Hippocampal Neurons: Molecular Heterogeneity of Synaptic Terminals , 1999, Molecular and Cellular Neuroscience.

[18]  V. Pickel,et al.  The Mammalian Brain High-Affinity l-Proline Transporter Is Enriched Preferentially in Synaptic Vesicles in a Subpopulation of Excitatory Nerve Terminals in Rat Forebrain , 1999, The Journal of Neuroscience.

[19]  S. Walkley Cellular Pathology of Lysosomal Storage Disorders , 1998, Brain pathology.

[20]  V. Ganapathy,et al.  Localization of peptide transporter in nuclei and lysosomes of the pancreas , 1997, International journal of pancreatology : official journal of the International Association of Pancreatology.

[21]  E. Preston,et al.  A comparison of cathepsin B processing and distribution during neuronal death in rats following global ischemia or decapitation necrosis 1 NRC Publication No.: 39536. 1 , 1997, Brain Research.

[22]  D. Witte,et al.  Tissue and cellular specific expression of murine lysosomal acid lipase mRNA and protein. , 1996, Journal of lipid research.

[23]  S. Takenoshita,et al.  Immuno-localization of H+/peptide cotransporter in rat digestive tract. , 1996, Biochemical and biophysical research communications.

[24]  T. Cox The metabolic and molecular bases of inherited disease: Vols I, II and III (7th edn): edited by Charles R. Scriver, Arthur L. Beaudet, William S. Sly and David Valle McGraw-Hill, 1995, £195.00 hbk (4605 pages) ISBN 0 07 909826 6 , 1996 .

[25]  R. Nixon,et al.  Properties of the endosomal-lysosomal system in the human central nervous system: disturbances mark most neurons in populations at risk to degenerate in Alzheimer's disease , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[26]  R. Nixon,et al.  The endosomal-lysosomal system of neurons: new roles , 1995, Trends in Neurosciences.

[27]  J. Portais,et al.  Comparative analysis of 13C-enriched metabolites released in the medium of cerebellar and cortical astrocytes incubated with [1-13C]glucose. , 1995, European journal of biochemistry.

[28]  R. Fremeau,et al.  Mammalian Brain-specific L-Proline Transporter. , 1995, The Journal of Biological Chemistry.

[29]  M. Garcia-Blanco,et al.  A Mammalian Activity Required for the Second Step of Pre-messenger RNA Splicing (*) , 1995, The Journal of Biological Chemistry.

[30]  M. Yudkoff,et al.  Cerebral Alanine Transport and Alanine Aminotransferase Reaction: Alanine as a Source of Neuronal Glutamate , 1994, Journal of neurochemistry.

[31]  M. Tsacopoulos,et al.  Glial cells transform glucose to alanine, which fuels the neurons in the honeybee retina , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[32]  M. Morales,et al.  Aggregation of vasopressin mRNA in a subset of axonal swellings of the median eminence and posterior pituitary: light and electron microscopic evidence , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[33]  A. Schousboe,et al.  Uptake, release and metabolism of alaume in neurons and astrocytes in primary cultures , 1993, Journal of neuroscience research.

[34]  J. Martinie,et al.  The pathway and targeting signal for delivery of the integral membrane glycoprotein LEP100 to lysosomes , 1992, The Journal of cell biology.

[35]  M. Fukuda,et al.  The lysosomal membrane glycoprotein lamp-1 is transported to lysosomes by two alternative pathways. , 1992, Archives of biochemistry and biophysics.

[36]  R. Blakely,et al.  Molecular cloning and expression of a high affinity l-proline transporter expressed in putative glutamatergic pathways of rat brain , 1992, Neuron.

[37]  I. Mellman,et al.  Transport of the lysosomal membrane glycoprotein lgp120 (lgp-A) to lysosomes does not require appearance on the plasma membrane , 1992, The Journal of cell biology.

[38]  R. Nixon,et al.  Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer disease. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[39]  I. Nabi,et al.  An endogenous MDCK lysosomal membrane glycoprotein is targeted basolaterally before delivery to lysosomes , 1991, The Journal of cell biology.

[40]  M. Fukuda,et al.  Lysosomal membrane glycoproteins. Structure, biosynthesis, and intracellular trafficking. , 1991, The Journal of biological chemistry.

[41]  A. Hubbard,et al.  Sequential processing of epidermal growth factor in early and late endosomes of rat liver. , 1991, The Journal of biological chemistry.

[42]  H. Geuze,et al.  Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments , 1991, Nature.

[43]  H. Blom,et al.  Characterization of lysosomal monoiodotyrosine transport in rat thyroid cells. Evidence for transport by system h. , 1990, The Journal of biological chemistry.

[44]  M. Wajner,et al.  High urinary excretion of N‐(pyrrole‐2‐carboxyl) glycine in type II hyperprolinemia , 1990, Clinical genetics.

[45]  R. Nixon,et al.  Enzymatically active lysosomal proteases are associated with amyloid deposits in Alzheimer brain. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[46]  E. Bird,et al.  Lysosomal proteinase antigens are prominently localized within senile plaques of Alzheimer's disease: evidence for a neuronal origin , 1990, Brain Research.

[47]  J. Phang,et al.  Type II hyperprolinaemia in a pedigree of Irish travellers (nomads). , 1989, Archives of disease in childhood.

[48]  E. Boltshauser,et al.  Hyperprolinaemia type I and white matter disease: Coincidence or causal relationship , 1989, European Journal of Pediatrics.

[49]  R. Brady,et al.  Niemann-Pick disease types C and D. , 1989, Neurologic clinics.

[50]  J. Slot,et al.  Sorting of mannose 6-phosphate receptors and lysosomal membrane proteins in endocytic vesicles , 1988, The Journal of cell biology.

[51]  W. Gahl,et al.  Defective sialic acid egress from isolated fibroblast lysosomes of patients with Salla disease. , 1986, Science.

[52]  E. Roberts,et al.  Proline, glutamate and glutamine metabolism in mouse brain synaptosomes , 1984, Brain Research.

[53]  Y. Yoneda,et al.  A New Synaptosomal Biosynthetic Pathway of Glutamate and GABA from Ornithine and Its Negative Feedback Inhibition by GABA , 1982, Journal of neurochemistry.

[54]  W. Whetsell,et al.  Immunocytochemical localization of cathepsin D in rat neural tissue , 1981, Brain Research.

[55]  S. Goodman,et al.  Defective hydroxyproline metabolism in type II hyperprolinemia. , 1974, Biochemical medicine.

[56]  Y. Eto,et al.  [Lysosomal transport disorders: cystinosis and sialic acid storage disorders]. , 1998, Ryoikibetsu shokogun shirizu.

[57]  B. L. Granger,et al.  Cell surface accumulation of overexpressed hamster lysosomal membrane glycoproteins. , 1995, Cellular & molecular biology research.

[58]  R. Pisoni,et al.  Amino Acid Transport by Lysosomes , 1992 .

[59]  Arthur J. L. Cooper,et al.  Amino Acid Transport in Brain , 1992 .

[60]  G. Guidotti,et al.  Amino Acid Transporters: Systematic Approach and Principles of Control , 1992 .

[61]  D. Häussinger,et al.  Mammalian Amino Acid Transport , 1992, Springer US.

[62]  E. Giacobini Imino Acids of the Brain , 1983 .

[63]  C. W. Adams,et al.  Handbook of Neurochemistry , 1983, Springer US.